GabrielLopez-BeresteinMD

Physician

Dr. Lopez-Berestein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1979 - 1981
San Juan City HospitalResidency, Internal Medicine, 1976 - 1979
Universidad de Navarra Faculty of MedicineClass of 1976

PubMed

Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, Mohammed H Rashed, Cristina Ivan
Ebiomedicine. 2024-12-04
MicroRNA-1307-3p contributes to breast cancer progression through PRM2.
José Roberto Estupiñan-Jiménez, Valeria Villarreal-García, Vianey Gonzalez-Villasana, Pablo E Vivas-Mejia, Jose Manuel Vazquez-Guillen
Thoracic Cancer. 2024-11-01
HIF-2α-dependent induction of miR-29a restrains T1 activity during T cell dependent colitis.
Agnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, Xiangsheng Huang, In Hyuk Bang
Nature Communications. 2024-09-14

Lectures

A pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy (CIPN).
2019 ASCO Annual Meeting - 6/1/2019

MD Anderson Research Highlights for December 19, 2022December 19th, 2022
New ERC President Mauro Ferrari Was Partner of Texas Cheater Anil SoodMay 17th, 2019